GLS and breast neoplasm: SLC7A5, SLC1A5, GLS and PIK3CA were significantly expressed in breast tumours with high expression of SLC3A2 (p < 0.001), while the low expression was associated with high levels of p-mTORC1 (p < 0.001, Supplementary Table 5).